In a recent study published in Science Translational Medicine, researchers evaluated the differential humoral immune response to two coronavirus disease 2019 (COVID-19) vaccines - messenger ...

Why Antibody Therapies Fail in Late-Stage Testing. Antibody therapies work in part by binding to Fc? receptors, proteins ...

New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of ...

A recent study published in Cell Reports demonstrated that vaccine-induced antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diminish with age. Study: BNT162b2 ...

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 [1] antibodies by applying cutting-edge microscopy techniques ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a ...

"The hybrid antibody is significantly better than the body's own antibodies at fighting both streptococcus and SARS-CoV-2", say the researchers behind the discovery. Brief facts about the study: basic ...

Ever since linking loss-of-function mutations in the microglial gene TREM2 to a higher risk of Alzheimer’s disease, scientists have been developing antibodies to boost TREM2 signaling. The latest? A ...

Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated ...